Germline Genetic Variation Modulates Tumor Progression and Metastasis in a Mouse Model of Neuroendocrine Prostate Carcinoma

The C57BL/6J Mouse Strain Background Modifies the Effect of a Mutation in Bcl2l2

(2012) Stefanie J. Navarro et al.   G3-Genes Genomes Genetics

FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer

(2011) Josefine Gerhardt et al.   AMERICAN JOURNAL OF PATHOLOGY

Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

(2011) H. Beltran et al.   Cancer Discovery

Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors

(2010) Jianfei Qi et al.   CANCER CELL

Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer

(2009) Qianben Wang et al.   CELL

The Future of Mouse QTL Mapping to Diagnose Disease in Mice in the Age of Whole-Genome Association Studies

(2008) Kent W. Hunter et al.   Annual Review of Genetics

The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival

(2008) Nigel P. S. Crawford et al.   CLINICAL & EXPERIMENTAL METASTASIS

Bromodomain 4 activation predicts breast cancer survival

(2008) N. P. S. Crawford et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy

(2008) Kerstyn M. Haram et al.   PROSTATE

Dissociation of Epithelial and Neuroendocrine Carcinoma Lineages in the Transgenic Adenocarcinoma of Mouse Prostate Model of Prostate Cancer

(2007) Teresa Chiaverotti et al.   AMERICAN JOURNAL OF PATHOLOGY